Robotic Ovarian Surgery May Increase Both Costs and Complications Interview with:
Jason D. Wright, M.D.
Sol Goldman Associate Professor of Obstetrics and Gynecology
Chief, Division of Gynecologic Oncology
Columbia University College of Physicians and Surgeons
New York, New York 10032

Medical Research: What are the main findings of the study?

Dr. Wright: The use of robotic assisted ovarian surgery (oophorectomy and cystectomy) has increased rapidly and compared to laparoscopic alternatives, robotically assisted surgery is associated with a small increase in complication rates and substantially greater costs.

Medical Research: What was most surprising about the results?

Dr. Wright: We noted a rapid increase in the use of robotic-assisted adnexal surgery despite minimal data.

Medical Research: What should clinicians and patients take away from your report?

Dr. Wright: Our findings suggest that robotic ovarian surgery is associated with a small increase in intraoperative complications and significant costs. It is unclear if there are specific groups of women who may benefit from these techniques.

Medical Research: What recommendations do you have for future research as a result of this study?

Dr. Wright: Based on these findings, further studies to examine the effectiveness of robotic-assisted ovarian cancer surgery are needed prior to wide spread use of the procedures.



Comparative Effectiveness of Robotic-Assisted Compared to Laparoscopic Adnexal Surgery for Benign Gynecologic Disease

Alessandra Kostolias, MD (CUMC), Cande V. Ananth, PhD, MPH (CUMC), William M. Burke, MD (CUMC), Ana I. Tergas, MD (CUMC), Eri Prendergast, MS (CUMC), Scott D. Ramsey, MD, PhD (Fred Hutchinson Cancer Research Center), and Alfred I. Neugut, MD, PhD (CUMC).

Obstetrics & Gynecology:: October 6, 2014
doi: 10.1097/AOG.0000000000000483